Khiron Life Sciences Corp., a Canada-based company engaged in alternative medicine sector, announced that Joel Friedman has resigned as Chief Financial Officer. “Joel Friedman, has resigned as Chief Financial Officer of the Company for personal reasons,” the company said in its release.
Khiron’s board of directors has appointed Swapan Kakumanu of RTB LLP to the role of Interim CFO, effective immediately. Friedman will remain with Khiron until October 31, 2021 to provide transitional support.
Alvaro Torres, Khiron CEO and Director, commented: “On behalf of the Board of Directors and the management team, I would like to thank Joel for his contributions and leadership to our strong finance team and wish him the best in his future endeavours.”
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.